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Article focus
  Few studies have assessed the outcomes 
following non-metal-on-metal hip 
arthroplasty (non-MoMHA) revision 
surgery performed for adverse reactions 
to metal debris (ARMD), despite this clin-
ical problem being increasingly reported 
worldwide.
outcomes following revision surgery 
performed for adverse reactions to 
metal debris in non-metal-on-metal hip 
arthroplasty patients
ANAlysis oF 185 RevisioNs FRoM tHe NAtioNAl JoiNt RegistRy  
FoR eNglAND AND WAles
Objectives
Few studies have assessed outcomes following non-metal-on-metal hip arthroplasty (non-
MoMHA) revision surgery performed for adverse reactions to metal debris (ARMD). We 
assessed outcomes following non-MoMHA revision surgery performed for ARMD, and iden-
tified predictors of re-revision.
Methods
We performed a retrospective observational study using data from the national Joint Regis-
try for england and Wales. All non-MoMHAs undergoing revision surgery for ARMD between 
2008 and 2014 were included (185 hips in 185 patients). outcome measures following 
ARMD revision were intra-operative complications, mortality and re-revision surgery. pre-
dictors of re-revision were identified using cox regression.
Results
Intra-operative complications occurred in 6.0% (n = 11) of the 185 cases. The cumulative 
four-year patient survival rate was 98.2% (95% cI 92.9 to 99.5). Re-revision surgery was 
performed in 13.5% (n = 25) of hips at a mean time of 1.2 years (0.1 to 3.1 years) following 
ARMD revision. Infection (32%; n = 8), dislocation/subluxation (24%; n = 6), and aseptic 
loosening (24%; n = 6) were the most common re-revision indications. The cumulative four-
year implant survival rate was 83.8% (95% cI 76.7 to 88.9). Multivariable analysis identified 
three predictors of re-revision: multiple revision indications (hazard ratio (HR) = 2.78; 95% 
cI 1.03 to 7.49; p = 0.043); selective component revisions (HR = 5.76; 95% cI 1.28 to 25.9; 
p = 0.022); and ceramic-on-polyethylene revision bearings (HR = 3.08; 95% cI 1.01 to 9.36; 
p = 0.047).
Conclusions
non-MoMHAs revised for ARMD have a high short-term risk of re-revision, with important 
predictors of future re-revision including selective component revision, multiple revision 
indications, and ceramic-on-polyethylene revision bearings. our findings may help counsel 
patients about the risks of ARMD revision, and guide reconstructive decisions. Future stud-
ies attempting to validate the predictors identified should also assess the effects of implant 
design (metallurgy and modularity), given that this was an important study limitation 
potentially influencing the reported prognostic factors.
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  this study aimed to determine the outcomes follow-
ing non-MoMHA revision surgery performed for 
ARMD using National Joint Registry data from england 
and Wales.
  Predictors of future re-revision surgery were also 
investigated.
Key messages
  Non-MoMHA patients undergoing ARMD revision 
surgery have a high risk of re-revision within four 
years, with infection, dislocation/subluxation, and 
aseptic loosening representing the most common re-
revision indications.
  Predictors of future re-revision risk were revision indi-
cations in addition to ARMD, selective component 
revision procedures, and ceramic-on-polyethylene 
revision bearings, with the last two representing 
potentially modifiable factors.
  the study findings may be used to counsel non-
MoMHA patients about the risks associated with 
ARMD revision, and to guide decisions about the type 
of reconstructive procedure to perform.
Strengths and limitations
  study strengths include using linked data from the 
world’s largest arthroplasty registry, and reporting on 
the entire population, which decreases the risk of 
sampling bias.
  A major limitation was not having specific implant 
design information available, such as manufacturer, 
metallurgy, and details regarding implant modular-
ity. the lack of such data has the potential to influ-
ence the reported prognostic factors (such as the 
importance of the revision bearing surface), and must 
be considered in future studies attempting to validate 
the present findings.
  An important limitation is that surgeons may have 
either incorrectly coded ARMD revisions using other 
indications (such as infection), or alternatively made a 
diagnosis of ARMD that was subsequently not con-
firmed histopathologically.
introduction
Metal-on-metal hip arthroplasty (MoMHA) has resulted 
in high short-term rates of failure.1,2 Many MoMHA revi-
sions have been performed for adverse reactions to metal 
debris (ARMD),3,4 with poor short-term outcomes 
reported following ARMD revision.5,6 Dislocation, recur-
rence of ARMD, and acetabular loosening represent the 
most common modes of failure following MoMHA revi-
sion for ARMD.7
Recent studies have reported on non-MoMHAs requir-
ing revision surgery for ARMD, with failures generally 
occurring in newer implant designs with large femoral 
head sizes.8-14 in the absence of metal-on-metal bearings, 
ARMD in non-MoMHAs has been attributed to wear and 
mechanically assisted crevice corrosion occurring at 
modular implant junctions (head-taper and taper-
stem).8-14 in light of these problems, patients with certain 
non-MoMHA designs now require regular follow-up, 
with a low threshold recommended for performing a sys-
tematic evaluation.15
Although a number of studies have observed ARMD 
failures after non-MoMHA,8-11,14 few have detailed the 
outcomes following revision surgery.16 three studies 
have reported short-term outcomes following ARMD 
revision surgery performed in non-MoMHAs (mean 
 follow-up 18 to 25 months), with two studies involving 
small cohorts.12,13,17 Complications (19% to 29%) and re-
revisions (8% to 29%) were frequently observed follow-
ing ARMD revision, with failures most commonly due to 
ARMD recurrence, dislocation and infection.12,13,17
At present, the true risk of ARMD failure in non-MoM-
HAs remains unknown. one recent study has estimated 
the risk of ARMD revision in non-MoMHAs to be 0.25%.12 
Although this is lower than the current 3.7% risk of ARMD 
revision in MoMHAs, it is worth acknowledging that the 
risk in MoMHA patients was 0.15% in 2009, which repre-
sents a time when little was known about ARMD in 
MoMHAs.3 given the widespread use of newer non-
MoMHA designs with large femoral head sizes and mod-
ular junctions,3,4 it is expected that the risk of ARMD 
revision surgery in non-MoMHA patients will increase 
with time. therefore, it is important that surgeons have 
information about the expected outcomes following 
ARMD revision so that patients can be appropriately 
counselled about the risks of further intervention. in addi-
tion, identifying prognostic factors of outcome following 
ARMD revision may assist decision-making about the 
reconstructive procedure and post-operative follow-up 
regimen. large cohort studies would help answer these 
important clinical questions.
the National Joint Registry (NJR) for england and 
Wales was established in April 2003 to identify poorly 
performing implants early, and is the world’s largest 
arthroplasty registry.3 We used NJR data to: (1) determine 
the outcomes following non-MoMHA revision surgery 
performed for ARMD; (2) establish the indications for re-
revision surgery; and (3) identify predictors of re-revision 
surgery.
patients and Methods
A retrospective observational study was performed using 
data from the NJR for england and Wales. Data were 
obtained on 07 December 2015. this dataset included 
details of all primary stemmed non-MoMHAs which sub-
sequently underwent revision surgery for adverse soft-
tissue reaction to particulate debris as recorded in the NJR 
between 01 June 2008 and 07 December 2014 (n = 
194). We have elected to classify this revision indication 
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as ARMD throughout, which is currently the most com-
monly used term.18 the former date is when the NJR 
introduced ARMD as a formal indication for revision sur-
gery. the latter date ensured outcomes after ARMD revi-
sion were reported at a minimum of one-year follow-up. 
Before obtaining the dataset, the NJR database was linked 
with the office for National statistics database (provides 
data on all-cause patient mortality and time to death) 
using unique patient identifiers.
Hips undergoing staged (two or more) revision proce-
dures for ARMD were subsequently excluded (n = 9). As 
registries do not record the results of microbiological and 
histopathological analysis of tissues excised at revision, it 
is possible that these staged procedures may have been 
performed for undiagnosed infection. the final cohort for 
analysis therefore included 185 primary non-MoMHAs in 
185 patients undergoing single-stage revision surgery for 
ARMD. Revision procedures were performed by 140 sur-
geons (surgeons performed between one and five cases) 
at 109 centres (between one and nine cases were carried 
out at each centre). these 185 revisions were either com-
plete revision procedures (all components from the pri-
mary arthroplasty were revised at revision) or selective 
component revision procedures. selective component 
revision procedures included cases where at least one 
component from the primary arthroplasty procedure was 
retained at revision. this included either the femoral or 
acetabular component being retained at revision, or both 
the femoral and acetabular components being retained, 
with revision of the femoral head and liner (with or with-
out the use of a taper adapter).
unique patient identifiers allowed linkage of all ARMD 
revision procedures to the primary non-MoMHA surgery 
as well as to any re-revisions. For all procedures, the NJR 
collects data on patient demographics (age, gender, body 
mass index (BMi), American society of Anesthesiologists 
grade19) and the surgical procedure (indication, venous 
thromboembolism prophylaxis, surgeon grade, approach, 
and the components implanted). NJR data for revision 
operations also include details of intra-operative findings. 
Patient and surgical factors relating to the ARMD revision 
were used as covariates when assessing predictors of re-
revision surgery. For the components implanted at pri-
mary and revision surgery, the NJR provided data on the 
bearing surface, femoral head size, and implant fixation. 
Although the NJR does collect data on the specific implant 
design and manufacturer of all arthroplasty components, 
this information was not approved for release due to ongo-
ing negotiations between the NJR and the various manu-
facturers. therefore, for the current study it was not 
possible to identify the specific implants used; the metal-
lurgy and nature of any modular junctions were not 
known.
study outcome measures were: intra-operative com-
plications during ARMD revision; all-cause mortality fol-
lowing ARMD revision; and all-cause re-revision surgery 
following ARMD revision. intra-operative complications 
recorded by the NJR include calcar crack, pelvic and/or 
femoral shaft penetration, trochanteric and/or femoral 
shaft fracture, and other complications.
Statistical analysis. All data analyses were performed 
using stata version 13.1 (stataCorp, College station, 
texas). Differences in patient and surgical factors 
between re-revised and non-re-revised hips were assessed 
using either unpaired t-tests or the Wilcoxon rank-sum 
test (numerical data), and either the chi-squared test or 
Fisher’s exact test (categorical data). Cumulative patient 
and implant survival rates following ARMD revision were 
determined using the Kaplan-Meier method. Re-revision 
surgery (removal or exchange of any component, which 
included isolated revisions of the femoral head and 
acetabular liner) was the endpoint for implant survival. 
Patients who had not died and who were not undergo-
ing re-revision were censored on the study end date (07 
December 2015).
Cox proportional hazards models (univariable and 
multivariable) were used to identify predictors of re- 
revision surgery. linearity of continuous predictors with 
outcome (re-revision) was assessed using fractional poly-
nomials, with data grouped if effects were non-linear. 
the proportional hazards assumption was examined and 
satisfied for all predictors. Covariates were included in 
the final multivariable model if p < 0.20 in the univaria-
ble analysis. the significance level for all analyses was p 
< 0.05, with 95% confidence intervals (Ci) also used.
Results
Revision surgery for ARMD was performed in 185 patients 
with 185 non-MoMHAs (table i). During the study 
period, 10 496 non-MoMHA revisions (with a linked pri-
mary non-MoMHA within the NJR) were performed for all 
causes.3 therefore, the risk of ARMD revision surgery in 
all revised non-MoMHAs with a linked primary was 1.8%. 
During the study period, 451 664 primary non-MoMHAs 
were implanted.3 therefore, the risk of ARMD revision 
surgery in all primary non-MoMHAs was 0.041%.
the non-MoMHA bearing surfaces most frequently 
revised for ARMD were metal-on-polyethylene (44.9%; 
n  = 83), followed by ceramic-on-ceramic (35.7%; 
n = 66), and ceramic-on-polyethylene (11.4%; n = 21). 
the femoral head size of the primary arthroplasty was 
most commonly 28 mm or less (38.9%; n = 72), fol-
lowed by 36 mm (35.1%; n = 65) and 32 mm (20.0%; 
n = 37). Primary acetabular (86.5%; n = 160) and femo-
ral (71.8%; n = 130) components were predominantly 
uncemented.
intra-operative complications. intra-operative complica-
tions occurred in 6.0% (n = 11) of hips. the most com-
mon complications were calcar fracture (n = 3) and 
greater trochanteric fracture (n = 3).
patient mortality. overall mortality following revision 
surgery was 1.1% (n = 2). Deaths occurred at 2.1 years 
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Table i. Patient and surgical factors for all non-metal-on-metal hip arthroplasties revised for adverse reactions to metal debris (ARMD), and in hips not undergo-
ing re-revision surgery compared with those undergoing re-revision surgery
Covariate All ARMD hip revisions 
(n = 185) (100%)
ARMD hip revisions not 
undergoing re-revision 
surgery (n = 160) (86.5%)
ARMD hip revisions 
undergoing re-revision 
surgery (n = 25) (13.5%)
p-value
Female 119 (64.3) 101 (63.1) 18 (72.0) 0.389
Age at revision (yrs), mean (sd) 66.4 (10.6) 67.0 (10.8) 62.8 (9.0) 0.046
BMi (kg/m2)*, mean (sd) 28.2 (5.0) 28.1 (4.9) 29.3 (6.5) 0.589
time from primary to revision (yrs), mean (sd) 3.1 (2.6) 3.2 (2.7) 2.8 (2.0) 0.363
Yr revision performed  
2008 to 2011 56 (30.3) 45 (28.1) 11 (44.0) 0.108
2012 to 2014 129 (69.7) 115 (71.9) 14 (56.0)  
ASA grade at revision  
1 33 (17.8) 30 (18.8) ‡ 0.234
2 128 (69.2) 107 (66.9) 21 (84.0)  
3 24 (13.0) 23 (14.4) ‡  
VTE – chemical  
lMWH (+/-other) 114 (61.6) 98 (61.3) 16 (64.0) 0.270
Aspirin only 10 (5.4) 9 (5.6) ‡  
other 52 (28.1) 47 (29.4) ‡  
None 9 (4.9) 6 (3.8) ‡  
vte – mechanical (any versus none) 180 (97.3) 155 (96.9) 25 (100) 1.00
Revision surgeon grade (consultant versus other) 176 (95.1) 152 (95.0) 24 (96.0) 1.00
surgical approach (posterior versus other) 127 (68.7) 108 (67.5) 19 (76.0) 0.394
Revision indications/intra-operative findings  
ARMD (+/-pain) only 82 (44.3) 74 (46.3) 8 (32.0) 0.182
Additional indications 103 (55.7) 86 (53.8) 17 (68.0)  
ARMD 185 (100) § § §
Pain 41 (22.2) § § §
Aseptic loosening (any) 45 (24.3) § § §
Acetabular 27 (14.6)  
Femoral 23 (12.4)  
osteolysis (any) 21 (11.4) § § §
Acetabular 13 (7.0)  
Femoral 13 (7.0)  
other abnormal findings ‡ § § §
implant malalignment 18 (9.7) § § §
Acetabular liner wear 23 (12.4) § § §
Fracture 9 (4.9) § § §
Dislocation/subluxation 17 (9.2) § § §
infection ‡ § § §
incorrect implant size ‡ § § §
liner dissociation 8 (4.3) § § §
implant fracture 9 (4.9) § § §
Revision procedure  
selective component† 134 (72.4) 111 (69.4) 23 (92.0) 0.017
All component 51 (27.6) 49 (30.6) ‡  
Revision femoral head size (mm)*  
Mean (sd) 33.1 (3.7) 33.1 (3.6) 33.1 (4.3) 0.969
Range 22.25 to 40 22.25 to 40 22.25 to 40  
 ≤ 28 42 (23.5) 37 (23.7) ‡ 0.975
32 52 (29.1) 45 (28.9) 7 (30.4)  
 ≥ 36 85 (47.5) 74 (47.4) 11 (47.8)  
Revision bearing* (n, %)  
MoP 87 (51.5) 81 (54.7) 6 (28.6) 0.072
CoC 45 (26.6) 37 (25.0) 8 (38.1)  
CoP 37 (21.9) 30 (20.3) 7 (33.3)  
Revision component fixation  
uncemented 90 (81.8) 81 (81.8) 9 (81.8) 1.00
Cemented 20 (18.2) 18 (18.2) ‡  
Revision stem fixation  
uncemented 43 (51.2) 39 (50.0) ‡ 0.676
Cemented 41 (48.8) 39 (50.0) ‡  
Bone graft (femoral) 7 (3.8) 7 (4.4) 0 (0) 0.596
Bone graft (acetabular) 27 (14.6) 22 (13.8) ‡ 0.375
*missing data for stated number of hips: BMi (n = 72); revision femoral head size (n = 6); revision bearing surface (n = 16)
†selective component revision procedures included cases where at least one component from the primary arthroplasty procedure was retained at revision. this included 
either the femoral or acetabular component being retained at revision, or both the femoral and acetabular components being retained, with revision of the femoral head 
and liner (with or without the use of a taper adapter)
‡data suppressed due to small count within the cell. the actual number was between one and five
§due to small numbers, statistical comparisons between hips re-revised and hips not re-revised have not been performed for the individual revision indications
AsA, American society of Anesthesiologists; BMi, body mass index; CoC, ceramic-on-ceramic; CoP, ceramic-on-polyethylene; lMWH, low-molecular weight heparin; MoP, 
metal-on-polyethylene; vte, venous thromboembolism
All values in the table are number, with the percentages in brackets, unless otherwise indicated
statistically significant differences between the re-revised and non re-revised hips (p < 0.05) are highlighted in bold text
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and 2.4 years following ARMD revision; neither patient 
underwent re-revision surgery before death. the cumula-
tive four-year patient survival rate following ARMD revi-
sion was 98.2% (95% Ci 92.9 to 99.5).
Re-revision surgery. Re-revision surgery was performed 
in 13.5% (n = 25) of hips at a mean time of 1.2 years 
(0.1 to 3.1 years) following ARMD revision. in hips under-
going re-revision, 32% (n = 8) had more than one indi-
cation for failure. infection (32%; n = 8), dislocation or 
subluxation (24%; n = 6), and aseptic loosening (24%; 
n = 6) were the most common re-revision indications 
(table ii). the mean follow-up time for hips not undergo-
ing re-revision surgery was 3.1 years (1.0 to 7.2 years). 
the cumulative four-year implant survival rate following 
ARMD revision was 83.8% (95% Ci 76.7 to 88.9) (Fig. 1). 
the risk of re-revision surgery by type of initial revision 
procedure performed was as follows: 36% (9/25) acetab-
ular component only revision; 36% (9/25) femoral head 
and liner exchange alone; 20% (5/25) femoral compo-
nent only revision; 8% (2/25) all component revision.
predictors of re-revision surgery. univariable analysis 
identified the type of revision procedure performed as 
the only significant predictor of re-revision surgery (table 
iii). selective component revision procedures were asso-
ciated with an increased risk of re-revision compared with 
all component revisions (hazard ratio (HR) = 5.01; 95% 
Ci 1.18 to 21.3; p = 0.029).
in an adjusted multivariable model, three significant 
predictors of re-revision surgery were identified. Hips with 
revision indications in addition to ARMD (+/-pain) had a 
higher risk of re-revision compared with hips revised for 
ARMD (+/-pain) alone (HR = 2.78; 95% Ci 1.03 to 7.49; 
p  = 0.043). selective component revision procedures 
were associated with an increased risk of re-revision com-
pared with all component revisions (HR = 5.76; 95% Ci 
1.28 to 25.9; p = 0.022). Ceramic-on-polyethylene revi-
sion bearings had an increased risk of re-revision com-
pared with hips revised with metal-on-polyethylene 
bearings (HR = 3.08; 95% Ci 1.01 to 9.36; p = 0.047).
Discussion
Failure of non-MoMHA designs due to ARMD represents 
an emerging clinical problem.8-14 early outcomes follow-
ing ARMD revision surgery performed in MoMHA patients 
have largely been poor.5-7 However, little is known about 
the outcomes following ARMD revision performed in 
non-MoMHA patients, with previous studies involving 
small cohorts.12,13 Analysis of a large cohort of ARMD revi-
sion procedures performed in non-MoMHAs has dem-
onstrated that patients have a high risk of re-revision 
surgery within four years. Predictors of future re- 
revision were revision indications in addition to ARMD, 
selective component revision procedures, and ceramic-
on-polyethylene revision bearings.
Outcomes: intra-operative complications and patient 
mortality. the frequency of intra-operative complica-
tions in hips undergoing ARMD revision observed in this 
study was similar to that found in previous non-MoMHA 
Table ii. indications for hips undergoing re-revision surgery following revision surgery performed for adverse reactions to metal debris (n = 25)
Re-revision indications and intra-operative findings Number of events (%)
All indications  
overall 37 in 25 re-revised hips
Hips with one re-revision indication 17 (68)
Hips with two to four re-revision indications 8 (32)
Deep infection 8 (32)
Dislocation/subluxation 6 (24)
Aseptic loosening (acetabular or femoral) 6 (24)
Adverse reactions to metal debris 3 (12)
osteolysis (acetabular or femoral) 3 (12)
Pain 3 (12)
liner dissociation 3 (12)
other (including femoral malalignment, periprosthetic fracture, and implant fracture) 5 (20)
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Fig. 1
implant survival rate following revision surgery performed for adverse reac-
tions to metal debris at up to four years. shaded area represents the respective 
upper and lower limits of the 95% confidence intervals (Cis). Risk table indi-
cates the number of hips at risk at one-year intervals, with the corresponding 
number in brackets detailing the number of hips undergoing re-revision sur-
gery during each one-year interval. the cumulative four-year implant survival 
rate was 83.8% (95% Ci 76.7 to 88.9).
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revision cohorts.20,21 Fractures of the proximal femur 
were the most common intra-operative complication in 
all studies, which illustrates the potential difficulty associ-
ated with removing well-fixed stemmed components.20,21 
in addition, the risk of mortality following ARMD revision 
was observed to be low in our series, which is in line with 
previous work.3,22
Outcomes: re-revision surgery. the short-term risk of re-
revision following ARMD revision surgery in non-MoMHA 
patients was high. the proportion of re-revisions in our 
series (13.5%) was comparable with that observed fol-
lowing ARMD revision in non-MoMHA patients (8% to 
29%),12,13,17 though these previous reports had shorter 
follow-up periods compared with the current study. the 
implant survival rate following ARMD revision of 83.8% 
at four years was similar to that reported in the only 
other large cohort of non-MoMHA ARMD revisions (86% 
at 2.5 years).17 However, our reported implant survival 
following ARMD revision represents the best-case sce-
nario because registries may underreport arthroplasty 
failures.23,24 if the early observations of outcomes follow-
ing ARMD revision in MoMHA patients are excluded,5 
implant survival following non-MoMHA revision for 
ARMD appears inferior to both that reported follow-
ing MoMHA revision for ARMD25-27 and following revi-
sion of non-MoMHAs for conventional indications.28,29 
even when compared with data from the same registry, 
the re-revision rates following ARMD revision surgery 
Table iii. univariable and multivariable Cox regression analysis to identify predictors of re-revision surgery following revision surgery performed for adverse 
reactions to metal debris (ARMD)
Covariate Univariable hazard ratio 
(95% Ci)
p-value Multivariable hazard ratio 
(95% Ci)
p-value
gender (female versus male) 1.41 (0.59 to 3.37) 0.443 * *
Age at revision (per yr) 0.97 (0.94 to 1.00) 0.072 0.97 (0.93 to 1.01) 0.165
BMi (per kg/m2) 1.04 (0.93 to 1.17) 0.464 * *
time from primary to revision (per yr) 0.96 (0.82 to 1.13) 0.659 * *
ASA grade at revision  
1 1.00 Ref * *
2 1.95 (0.58 to 6.54) 0.280  
⩾ 3 0.46 (0.05 to 4.44) 0.504  
VTE – chemical  
None 1.00 Ref 1.00 Ref
lMWH (+/-other) 0.47 (0.14 to 1.60) 0.227 0.26 (0.07 to 1.02) 0.053
Aspirin only 0.28 (0.03 to 2.70) 0.271 0.35 (0.03 to 3.65) 0.378
other 0.31 (0.07 to 1.31) 0.111 0.21 (0.04 to 1.05) 0.057
vte – mechanical (any versus none) † † * *
Revision surgeon grade (consultant versus other) 1.23 (0.17 to 9.06) 0.842 * *
surgical approach (posterior versus other) 1.48 (0.59 to 3.70) 0.407 * *
Revision indications  
ARMD (+/-pain) only 1.00 Ref 1.00 Ref
Additional indications 1.76 (0.76 to 4.09) 0.186 2.78 (1.03 to 7.49) 0.043
Revision procedure‡  
All components revised 1.00 Ref 1.00 Ref
selective component revision 5.01 (1.18 to 21.3) 0.029 5.76 (1.28 to 25.9) 0.022
Revision femoral head size (in mm)  
⩽ 28 1.00 Ref * *
32 1.09 (0.35 to 3.44) 0.882  
⩾ 36 1.11 (0.39 to 3.20) 0.845  
Revision bearing  
MoP 1.00 Ref 1.00 Ref
CoC 2.84 (0.98 to 8.18) 0.054 1.79 (0.54 to 5.89) 0.339
CoP 2.96 (1.00 to 8.83) 0.051 3.08 (1.01 to 9.36) 0.047
Revision cup fixation  
uncemented 1.00 Ref * *
Cemented 0.99 (0.21 to 4.60) 0.993  
Revision stem fixation  
uncemented 1.00 Ref * *
Cemented 0.51 (0.09 to 2.80) 0.440  
Bone graft (femoral) † † * *
Bone graft (acetabular) 1.31 (0.49 to 3.50) 0.590 * *
*covariate was not eligible for inclusion in the final multivariable model
†unable to calculate value as no hips in this subgroup underwent re-revision surgery
‡selective component revision procedures included cases where at least one component from the primary arthroplasty procedure was retained at revision. 
this included either the femoral or acetabular component being retained at revision, or both the femoral and acetabular components being retained, with 
revision of the femoral head and liner (with or without the use of a taper adapter)
AsA, American society of Anesthesiologists; BMi, body mass index; Ci, confidence interval; CoC, ceramic-on-ceramic; CoP, ceramic-on-polyethylene; lMWH, 
low-molecular weight heparin; Ref, reference group; MoP, metal-on-polyethylene; vte, venous thromboembolism
statistically significant differences (p < 0.05) have been highlighted in bold text
Due to missing BMi data, the univariable analysis for BMi was based on a cohort of 113 hip revisions with ten hips undergoing re-revision surgery
Multivariable analysis was based on a cohort of 167 hip revisions with 21 hips undergoing re-revision surgery
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in non-MoMHAs reported in this study are high. the 
five-year implant survival rates following all-cause non-
MoMHA revision surgery recorded in the NJR are 87.8% 
to 89.1% for primary metal-on-polyethylene arthroplas-
ties (depending on fixation), and 88.2% for primary 
uncemented ceramic-on-ceramic arthroplasties.3 this 
high short-term re-revision rate following ARMD revision 
in non-MoMHA patients is concerning. We therefore rec-
ommend careful surveillance of these patients following 
ARMD revision surgery.
Re-revisions following ARMD revision surgery were 
performed early (mean 1.2 years), with the most com-
mon re-revision indications similar to previous reports in 
both non-MoMHAs and MoMHAs revised for 
ARMD.7,12,13,17 Multiple surgeries, incomplete excision of 
metal debris/necrotic tissue, and retained components 
from the primary arthroplasty may contribute to deep 
infection following ARMD revision.7 Risk factors for hip 
instability include destructive ARMD lesions requiring 
extensive soft-tissue debridement, reduction of the femo-
ral head diameter, and cases where suboptimal primary 
component positioning may be accepted because of the 
potential risks associated with removing well-fixed ace-
tabular and femoral components.6,25 Aseptic loosening of 
revision components may occur because of ARMD-
induced osteolysis.6,7 Although ARMD recurrence has fre-
quently been reported following ARMD revision in both 
non-MoMHA and MoMHA patients,7,12,13,17 it was not 
commonly observed in the present study. this variance 
may be due to multiple factors, such as the different types 
of primary and revision implants used in each study, the 
severity of ARMD, and the completeness of ARMD exci-
sion performed. Further work is needed to understand 
why ARMD recurs following revision and how recurrence 
can be minimised.
predictors of re-revision surgery. our final multivari-
able model identified three predictors of future re-revi-
sion risk, all with large effect sizes. However, the lack of 
implant design data available for the revised arthroplasty 
(including manufacturer, metallurgy, and details about 
modularity) limits the clinical significance of the three 
predictors given that these implant design details may 
represent confounding factors that were truly respon-
sible for the associations identified in the present study.
Hips with revision indications in addition to ARMD were 
almost three times more likely to be re-revised compared 
with hips revised for ARMD alone. Aseptic loosening, ace-
tabular liner wear, osteolysis, implant malalignment, and 
dislocation/subluxation were the most common addi-
tional indications for revision (table i). Adverse intra-oper-
ative findings in addition to ARMD have frequently been 
reported in MoMHA patients.25,26,30 Although ARMD com-
plicated by other adverse features would be expected to 
be associated with inferior outcomes following revision, 
such a relationship has yet to be established in MoMHA 
revisions.25,26,30 We have identified multiple revision indi-
cations as a poor prognostic factor following ARMD revi-
sion in non-MoMHA patients. if these additional 
abnormalities reflect more advanced ARMD, the regular 
follow-up currently recommended for certain non-
MoMHA designs may assist detection of ARMD at an earlier 
stage with the potential for improved post-revision out-
comes. there is evidence that such an approach can 
improve outcomes in MoMHA patients revised for ARMD.25
the risk of re-revision was six times higher in hips 
undergoing selective component revision procedures 
compared with all component revisions, with 92% of re-
revisions in our series initially undergoing selective com-
ponent revisions. this mirrors observations following 
MoMHA revision.25,31 When performing ARMD revision 
surgery in patients with stemmed implants, well-fixed 
and adequately positioned components are frequently 
retained, with adapters used if tapers are not severely 
damaged or corroded.6,12,13,32 selective component revi-
sions reduce the perceived morbidity associated with 
removing well-fixed components.20,33 However, there is 
limited data to support this strategy in non-MoMHAs 
with ARMD. selective component revision was the 
strongest risk factor for re-revision in the present study. 
given the most common indications for re-revision (infec-
tion, instability and aseptic loosening), it is possible that 
these failures occurred due to occult or unrecognised 
infection or component loosening at the ARMD revision 
procedure. Furthermore, there can be difficulties optimis-
ing soft-tissue tension and component positioning 
(namely combined version) when performing selective 
revisions, which increases the risk of subsequent hip 
instability.6,12,13 therefore, our findings do not support 
selective component revision procedures as a universal 
approach for managing non-MoMHAs with ARMD. if sur-
geons do perform such revisions, it is important to coun-
sel patients pre-revision about the increased risk of future 
procedures. these patients should also undergo regular 
follow-up post-revision given the increased risk of short-
term failure.
Presently, there is no consensus on which bearing sur-
face to implant when revising non-MoMHAs for ARMD. 
Ceramic bearings and metal-on-polyethylene articulations 
have most commonly been used at revision, with a prefer-
ence for ceramic heads in order to avoid further taper cor-
rosion which can occur with metal femoral heads.12,13,17 
We observed ceramic-on-polyethylene revision bearings 
to have a three-fold increased risk of re-revision compared 
with hips revised with metal-on-polyethylene bearings. 
Registries have reported ceramic-on-polyethylene bear-
ings to have the lowest rates of failure when used in pri-
mary arthroplasty,3,4 therefore it is unclear why 
ceramic-on-polyethylene bearings had an increased risk 
of re-revision when used at ARMD revision. given that 
this finding reached borderline significance in the 
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multivariable model, and that there was no prior belief 
that ceramic-on-polyethylene revision bearings would be 
associated with a higher re-revision risk, we cannot 
exclude a type i error. As data were not available on 
implant design, metallurgy and the nature of any modu-
lar junctions, the study findings may have been con-
founded by factors that were not assessed. As a result, 
rates of failure may not truly be influenced by the revision 
bearing surface, but instead by factors which are associ-
ated with implantation of ceramic-on-polyethylene bear-
ings at revision, such as stem design or other unrecognised 
confounding factors. We recommend other large inde-
pendent datasets be assessed to determine the signifi-
cance of this particular result, with such analyses 
adjusting for any potential implant-related confounding 
factors.
Strengths and limitations. study strengths include using 
linked data from the world’s largest arthroplasty registry, 
which contains details of the primary surgery and any 
subsequent procedures. Furthermore, reporting on the 
entire population decreases the risk of sampling bias. it 
is therefore likely that our findings have good external 
validity and generalisability, however, this requires vali-
dation in future studies.
this study has a number of limitations. A major limita-
tion was not having specific implant design information 
available for the revised arthroplasty, such as the manu-
facturer, metallurgy, and details regarding implant mod-
ularity. the lack of such data has the potential to influence 
the reported prognostic factors (such as the importance 
of the revision bearing surface), which must be consid-
ered and adjusted for in future studies attempting to vali-
date the present findings. A further substantial limitation 
was that the absolute number of ARMD revisions and 
subsequent re-revisions was small, a fact which is sus-
pected to be largely responsible for the broad confidence 
intervals observed for the three significant predictors of 
re-revision surgery. Although this study can conclude 
that the three predictors of re-revision surgery were sta-
tistically significant, the true magnitude of the effect sizes 
for each predictor is less certain given the broad confi-
dence intervals. therefore, this study cannot definitively 
establish whether the predictors of re-revision identified 
were truly clinically significant. it is therefore important 
for further research to be performed in this area using 
larger cohorts of non-MoMHA patients undergoing 
ARMD revision, though this may be difficult given that 
only small cohorts have currently been reported.8-13 A 
further limitation is using observational data which makes 
it difficult to infer causality. our patient cohort was also 
subject to sampling bias. given ARMD associated with 
non-MoMHAs was only described recently,8-11 surgeons 
may have incorrectly coded ARMD revisions using other 
indications, namely infection. the NJR would not have 
captured such cases. By contrast, some surgeons may 
have made a diagnosis of ARMD that was subsequently 
not confirmed following histopathological and microbio-
logical analysis of intra-operative samples. such cases 
may therefore have been inappropriately included in the 
present study cohort. Furthermore, although we have 
classified these revisions as performed for ARMD, the aeti-
ology and pathogenesis of this condition remains 
unknown;8-14 we cannot be certain that the reaction is 
specifically to metal debris.
given the relatively small cohort size, it is possible that 
missing data for some variables, such as BMi and revision 
bearing surface, may have affected our analyses and sub-
sequent interpretation of the data. Although the multivari-
able models used to identify predictors of re-revision 
surgery were adjusted for other relevant clinical factors, 
the comparisons presented in table i were not adjusted 
statistically for multiple comparisons, which is acknowl-
edged as a limitation. As ARMD became a revision indica-
tion in the NJR in 2008,3 only short-term outcomes 
following revision were available. Despite using linked 
data, it is feasible that some re-revision procedures were 
not captured by the NJR.23,24 Registries do not record 
non-revision procedures (washouts or closed hip reduc-
tions) or patient-reported outcomes following revision.3,4 
Consequently, these endpoints could not be assessed but 
are acknowledged to be important when determining 
clinical outcomes following reconstructive procedures. 
Finally, our findings may not be applicable to non- MoMHA 
patients following staged ARMD revision procedures.
in conclusion, non-MoMHA patients undergoing 
ARMD revision surgery have a high risk of re-revision 
within four years. infection, dislocation/subluxation, and 
aseptic loosening were the most common re-revision 
indications. Predictors of future re-revision risk were revi-
sion indications in addition to ARMD, selective compo-
nent revision procedures, and ceramic-on-polyethylene 
revision bearings. our findings may be used to: (1) coun-
sel non-MoMHA patients about the risks associated with 
ARMD revision; and (2) guide decisions about the type of 
reconstructive procedure to perform. However, future 
studies are needed to assess the predictors identified. 
these should also assess the effects of implant design 
(manufacturer, metallurgy, and nature of the modular 
junctions), given that this was a significant study limita-
tion potentially influencing the reported prognostic fac-
tors (such as the importance of the revision bearing 
surface).
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